Explore the roles of NEDD4 and NEDD4L proteins as therapeutic targets in lung, prostate, and colorectal cancers through cutting-edge research.
Explore the science behind cyclin-dependent kinases (CDKs), their role in cancer progression, and the breakthrough inhibitors revolutionizing cancer treatment.
Discover how miR-218-5p acts as a powerful tumor suppressor in retinoblastoma by targeting NACC1 and inhibiting the AKT/mTOR signaling pathway.
Explore the role of Ubiquitin-Specific Peptidase 37 (USP37) in cancer development, metastasis, and its potential as a therapeutic target.
Explore how cIAP2 functions as a K63 ubiquitin ligase for RIP1 and how IAP BIR antagonists can trigger cancer cell death through programmed apoptosis pathways.
Exploring the role and clinical implications of proteasome inhibition in medulloblastoma, a devastating childhood brain tumor.
Discover how pevonedistat and belinostat work synergistically to combat Acute Myeloid Leukemia by disrupting DNA repair mechanisms and triggering cancer cell death.
Explore how BRCA1 functions as a ubiquitin ligase, targeting specific proteins for destruction to prevent cancer development through DNA repair mechanisms.
Discover how XPC protein collaborates with MDM2 to degrade p53 tumor suppressor, revealing new insights into cancer mechanisms and potential therapies.
Explore how transcriptional regulation controls gene expression and its crucial role in cancer and metabolic diseases. Learn about groundbreaking research and future therapeutic approaches.